Dixit Lab News
Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research
- July 31, 2018
In the search for obesity treatments, scientists recently zeroed in on a gene known as Nucleobindin-2 (Nucb2), which was believed to play a role in satiety. However, in a new study published in Cell Reports, Yale researchers uncovered an unexpected function for the gene in reducing inflammation.
- July 24, 2018
Vishwa Deep Dixit, newly named as the Waldemar Von Zedtwitz Professor of Comparative Medicine, studies the interaction between immune and metabolic systems with the goal of revealing targets that can be harnessed to extend the healthspan — the period of life that is free of disabilities and disease.
- June 22, 2018
When it met on June 8, 2018 the Yale Corporation approved the following medical school faculty for endowed professorships.
- November 17, 2017
A list of awards won by Dixit Lab Members
- September 27, 2017
In a new study, Yale researchers have described how nervous systems and immune systems talk to each other to control metabolism and inflammation. Their finding furthers scientists’ understanding of why older adults fail to burn stored belly fat, which raises the risk of chronic disease. The study also points to potential therapeutic approaches to target the problem, the researchers said.
- October 31, 2016
The Yale Diabetes Research Center Symposium is scheduled to be held on November 15, 2016. Featured speakers include Stuart Weinzimer, MD; Richard Kibbey, MD, PhD; Vishwas Deep Dixit, DVM, PhD; and Domenico Accili, MD.
- September 23, 2016
Professor of Comparative Medicine and of Immunobiology Vishwa Deep Dixit, and his colleagues at Yale School of Medicine and UT Southwestern, have been awarded nearly $10.5 million in funding over five years from the National Institute on Aging.
- September 06, 2016Source: Connecticut
Beginning in 2007, Vishwa Deep Dixit, professor of comparative medicine and immunobiology at Yale School of Medicine, and a team of researchers at his lab began studying the hormone and its effects on mice genetically engineered to produce more of it.
- January 11, 2016
A hormone that extends lifespan in mice by 40% is produced by specialized cells in the thymus gland, according to a new study by Yale School of Medicine researchers. The team also found that increasing the levels of this hormone, called FGF21, protects against the loss of immune function that comes with age.